Phillip G. Nelson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Phillip G. Nelson has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Maria Angel Lanuza
Universitat Rovira i Virgili, Unitat d’Histologia i Neurobiologia (UHNeurob), Facultat de Medicina i Ciències de la Salut, Reus, Spain
3 shared publications Min Jia
National Institute of Child Health and Human Development, NIH
3 shared publicationsMin-Xu Li
National Institute of Child Health and Human Development, NIH
3 shared publicationsVeronica Dunlap
Laboratory of Developmental Neurobiology, The National Institute of Child Health and Human Development, The National Institutes of Health, Bethesda, Maryland
2 shared publicationsA. M. Ades
Children’s National Medical Center
1 shared publicationAlexa Viloria
Laboratory of Developmental Neurobiology, The National Institute of Child Health and Human Development, The National Institutes of Health, Bethesda, Maryland
1 shared publication
Latest Publications
- 22 March 2006
- Published by Wiley in Journal of Neuroscience Research
- Vol. 83 (8) , 1407-1414
Phosphorylation of the nicotinic acetylcholine receptor in myotube‐cholinergic neuron cocultures
Acetylcholine receptor (AChR) stability in the postsynaptic membrane is affected by serine kinases. AChR are phosphorylated by protein kinase C (PKC) and PKA, and we have shown that activation of PKA and PKC have opposite effects on AChR stability and that this may play some role in the selective, activity-dependent synapse loss that occurs during development of the neuromuscular junction. Myotube cultures with and without added spinal motor neurons were probed with immunoaffinity-purified antibodies prepared against phosphorylated peptides with amino acid sequences from different AChR subunits. Different treatments activating PKC (phorbol 12-myristate 13-acetate; PMA) or PKA (dibutyryl cyclic adenosine monophosphate; cAMP) or blocking electrical activity (tetrodotoxin; TTX) of the cocultures were chosen because of their known effects, direct or indirect, on receptor stability. We asked whether the phospho-specific antibody staining in conjunction with α-bungarotoxin (BTX) identification of AChR aggregates could provide a direct demonstration of changes in receptor phosphorylation produced by the treatments. We found that PMA treatment did increase phosphorylation of the delta subunit and cAMP increased phosphorylation of the epsilon subunit relative to total BTX labeling in muscle-nerve cocultures, but not in muscle-only cultures. Blockade of electrical activity with TTX increased the incidence of aggregates that showed no phospho-epsilon staining. Myotube cultures grown in the absence of neurons did not show the responses of myotubes in cocultures. The results show that manipulations that alter receptor stability also produce changes in receptor phosphorylation. We suggest that phosphorylation may be a mechanism mediating the changes in receptor stability.
- 22 March 2006
- Published by Wiley in Journal of Neuroscience Research
- Vol. 83 (8) , 1407-1414
Phosphorylation of the nicotinic acetylcholine receptor in myotube‐cholinergic neuron cocultures
Acetylcholine receptor (AChR) stability in the postsynaptic membrane is affected by serine kinases. AChR are phosphorylated by protein kinase C (PKC) and PKA, and we have shown that activation of PKA and PKC have opposite effects on AChR stability and that this may play some role in the selective, activity-dependent synapse loss that occurs during development of the neuromuscular junction. Myotube cultures with and without added spinal motor neurons were probed with immunoaffinity-purified antibodies prepared against phosphorylated peptides with amino acid sequences from different AChR subunits. Different treatments activating PKC (phorbol 12-myristate 13-acetate; PMA) or PKA (dibutyryl cyclic adenosine monophosphate; cAMP) or blocking electrical activity (tetrodotoxin; TTX) of the cocultures were chosen because of their known effects, direct or indirect, on receptor stability. We asked whether the phospho-specific antibody staining in conjunction with α-bungarotoxin (BTX) identification of AChR aggregates could provide a direct demonstration of changes in receptor phosphorylation produced by the treatments. We found that PMA treatment did increase phosphorylation of the delta subunit and cAMP increased phosphorylation of the epsilon subunit relative to total BTX labeling in muscle-nerve cocultures, but not in muscle-only cultures. Blockade of electrical activity with TTX increased the incidence of aggregates that showed no phospho-epsilon staining. Myotube cultures grown in the absence of neurons did not show the responses of myotubes in cocultures. The results show that manipulations that alter receptor stability also produce changes in receptor phosphorylation. We suggest that phosphorylation may be a mechanism mediating the changes in receptor stability.
- 23 February 2005
- Published by Wiley in Journal of Cellular Physiology
- Vol. 203 (3) , 501-509
Multiple acute effects on the membrane potential of PC12 cells produced by nerve growth factor (NGF)
We studied whether nerve growth factor (NGF) can affect the membrane potential and conductance of PC12 cells. We demonstrate that NGF depolarizes the membrane of PC12 cells within a minute and by using transfected NIH 3T3‐Trk and ‐p75 cells we show that both the high affinity NGF receptor p140trk and the low affinity NGF receptor or p75NGF may be involved in the depolarization. Tyrosine kinase inhibitor, K252a, partially inhibited the depolarization, but two agents affecting intracellular calcium movements, Xestospongin C (XeC) and thapsigargin, did not. The early depolarization was eliminated in Na+ free solutions and under this condition, a ‘prolonged’ (>2 min) hyperpolarization was observed in PC12 cells in response to NGF. This hyperpolarization was also induced in PC12 cells by epidermal growth factor (EGF). Voltage clamp experiments showed that NGF produced a late (>2 min) increase in membrane conductance. The Ca2+‐dependent BK‐type channel blocker, iberiotoxin, and the general Ca2+‐dependent K+ channel blocker, TEA, attenuated or eliminated the hyperpolarization produced by NGF in sodium free media. Under pretreatment with the non‐selective cation channel blockers La3+ and Gd3+, NGF hyperpolarized the membrane of PC12 cells. These results suggest that three different currents are implicated in rapid NGF‐induced membrane voltage changes, namely an acutely activated Na+ current, Ca2+‐dependent potassium currents and non‐selective cation currents. Published 2005 Wiley‐Liss, Inc.
- 23 February 2005
- Published by Wiley in Journal of Cellular Physiology
- Vol. 203 (3) , 501-509
Multiple acute effects on the membrane potential of PC12 cells produced by nerve growth factor (NGF)
We studied whether nerve growth factor (NGF) can affect the membrane potential and conductance of PC12 cells. We demonstrate that NGF depolarizes the membrane of PC12 cells within a minute and by using transfected NIH 3T3‐Trk and ‐p75 cells we show that both the high affinity NGF receptor p140trk and the low affinity NGF receptor or p75NGF may be involved in the depolarization. Tyrosine kinase inhibitor, K252a, partially inhibited the depolarization, but two agents affecting intracellular calcium movements, Xestospongin C (XeC) and thapsigargin, did not. The early depolarization was eliminated in Na+ free solutions and under this condition, a ‘prolonged’ (>2 min) hyperpolarization was observed in PC12 cells in response to NGF. This hyperpolarization was also induced in PC12 cells by epidermal growth factor (EGF). Voltage clamp experiments showed that NGF produced a late (>2 min) increase in membrane conductance. The Ca2+‐dependent BK‐type channel blocker, iberiotoxin, and the general Ca2+‐dependent K+ channel blocker, TEA, attenuated or eliminated the hyperpolarization produced by NGF in sodium free media. Under pretreatment with the non‐selective cation channel blockers La3+ and Gd3+, NGF hyperpolarized the membrane of PC12 cells. These results suggest that three different currents are implicated in rapid NGF‐induced membrane voltage changes, namely an acutely activated Na+ current, Ca2+‐dependent potassium currents and non‐selective cation currents. Published 2005 Wiley‐Liss, Inc.
- 1 June 2003
- Published by Springer Nature in Journal of Neurocytology
- Vol. 32 (5-8) , 803-816
Phosphorylation reactions in activity-dependent synapse modification at the neuromuscular junction during development
We have studied developmental activity-dependent synapse diminution in both an in vitrotissue culture chamber system and at the intact rodent neuromuscular junction (nmj). In both types of...
- 1 June 2003
- Published by Springer Nature in Journal of Neurocytology
- Vol. 32 (5-8) , 803-816
Phosphorylation reactions in activity-dependent synapse modification at the neuromuscular junction during development
We have studied developmental activity-dependent synapse diminution in both an in vitrotissue culture chamber system and at the intact rodent neuromuscular junction (nmj). In both types of...
- 1 April 2003
- Published by SAGE Publications in The Neuroscientist
- Vol. 9 (2) , 110-116
Protein Kinases and Hebbian Function
The Hebb synapse, in which the strength of synapses is affected by activity in presynaptic and postsynaptic nerve cells, is a widely used model for developmental and learning-related neuroplasticity. Presynaptic and postsynaptic firing that is correlated in time is postulated to increase synaptic strength while activity in presynaptic and postsynaptic neurons that is not correlated results in weakening. The authors describe a cell biologic, mechanistic model for activity-dependent modification of synapse strength that selectively weakens inactive inputs to activated targets. Differentially localized protein kinase A and protein kinase C molecules are activated by spike and synaptic activity. Subsequent kinase-specific phosphorylation and stabilization or destabilization of synaptic receptors are molecular and cell biologic substrates of the Hebb synapse. NEUROSCIENTIST 9(2): 110–116, 2003
- 1 April 2003
- Published by SAGE Publications in The Neuroscientist
- Vol. 9 (2) , 110-116
Protein Kinases and Hebbian Function
The Hebb synapse, in which the strength of synapses is affected by activity in presynaptic and postsynaptic nerve cells, is a widely used model for developmental and learning-related neuroplasticity. Presynaptic and postsynaptic firing that is correlated in time is postulated to increase synaptic strength while activity in presynaptic and postsynaptic neurons that is not correlated results in weakening. The authors describe a cell biologic, mechanistic model for activity-dependent modification of synapse strength that selectively weakens inactive inputs to activated targets. Differentially localized protein kinase A and protein kinase C molecules are activated by spike and synaptic activity. Subsequent kinase-specific phosphorylation and stabilization or destabilization of synaptic receptors are molecular and cell biologic substrates of the Hebb synapse. NEUROSCIENTIST 9(2): 110–116, 2003
- 1 January 2001
- Published by Springer Nature
- No. 61,p. 85-94
Glial-neurotrophic mechanisms in Down syndrome
Complex interactions and interconnectivity between neurons are hallmarks of normal neuronal differentiation and development. Neurons also interact with other cell types, notably glia, and rely on substances released by glia for their normal function. A deficit in glial response may disturb this critical neuronal-glial-neuronal interaction in Down syndrome (DS), leading to loss of neurons and other defects of development, and contribute to cognitive limitation and early onset of Alzheimer disease. The hypothesis this paper will discuss is that normal neural development involves an activity-dependent release of substances from neurons, and that these substances act upon glia cells which in turn release substances that influence neurons to promote their survival and development. This glial influence affects cortical neurons and also the subcortical cholinergic neurons that project to the cerebral and hippocampal cortices to maintain cortical neuronal excitability and activity. The neuronal activity stimulates glial secretion of sustaining substances, in a reciprocally interactive cycle. Some aspect of this “virtuous cycle” is deficient in Down syndrome. The result is a small but slowly increasing deficit in activity-dependent support by glia cells which produces a gradually increasing abnormality of cortical and subcortical, perhaps especially cholinergic, function.
- 1 January 2001
- Published by Springer Nature
- No. 61,p. 85-94
Glial-neurotrophic mechanisms in Down syndrome
Complex interactions and interconnectivity between neurons are hallmarks of normal neuronal differentiation and development. Neurons also interact with other cell types, notably glia, and rely on substances released by glia for their normal function. A deficit in glial response may disturb this critical neuronal-glial-neuronal interaction in Down syndrome (DS), leading to loss of neurons and other defects of development, and contribute to cognitive limitation and early onset of Alzheimer disease. The hypothesis this paper will discuss is that normal neural development involves an activity-dependent release of substances from neurons, and that these substances act upon glia cells which in turn release substances that influence neurons to promote their survival and development. This glial influence affects cortical neurons and also the subcortical cholinergic neurons that project to the cerebral and hippocampal cortices to maintain cortical neuronal excitability and activity. The neuronal activity stimulates glial secretion of sustaining substances, in a reciprocally interactive cycle. Some aspect of this “virtuous cycle” is deficient in Down syndrome. The result is a small but slowly increasing deficit in activity-dependent support by glia cells which produces a gradually increasing abnormality of cortical and subcortical, perhaps especially cholinergic, function.
- 30 August 2000
- Published by Wiley in Journal of Neuroscience Research
- Vol. 61 (6) , 616-625
Protein kinase C-mediated changes in synaptic efficacy at the neuromuscular junction in vitro: The role of postsynaptic acetylcholine receptors
Activation of a mouse in vitro neuromuscular synapse produces a reduction in synaptic efficacy which is greater for nonactivated than for activated inputs to the myotubes. This has been shown to require thrombin and thrombin receptor activation and to involve a protein kinase C (PKC)‐mediated step. We show in the present work that phorbol ester activation of PKC produces physiological loss of synapses in a time‐ and dose‐related manner. We observe, using quantitative imaging methods, a parallel loss of acetylcholine receptors (AChR) from synaptically functional neurite‐associated receptor aggregates in nerve‐muscle cocultures. Biochemical measurements of total AChR show that PKC activation reduces both AChR stability (increases receptor loss) and receptor insertion into the surface membrane. Taken together, the data suggest that PKC activation decreases the stability of AChR aggregates in the muscle surface membrane. We conclude that PKC plays a crucial role in activity‐dependent synapse reduction and does so, at least in part, by altering AChR stability. J. Neurosci. Res. 61:616–625, 2000. Published 2000 Wiley‐Liss, Inc.
- 30 August 2000
- Published by Wiley in Journal of Neuroscience Research
- Vol. 61 (6) , 616-625
Protein kinase C-mediated changes in synaptic efficacy at the neuromuscular junction in vitro: The role of postsynaptic acetylcholine receptors
Activation of a mouse in vitro neuromuscular synapse produces a reduction in synaptic efficacy which is greater for nonactivated than for activated inputs to the myotubes. This has been shown to require thrombin and thrombin receptor activation and to involve a protein kinase C (PKC)‐mediated step. We show in the present work that phorbol ester activation of PKC produces physiological loss of synapses in a time‐ and dose‐related manner. We observe, using quantitative imaging methods, a parallel loss of acetylcholine receptors (AChR) from synaptically functional neurite‐associated receptor aggregates in nerve‐muscle cocultures. Biochemical measurements of total AChR show that PKC activation reduces both AChR stability (increases receptor loss) and receptor insertion into the surface membrane. Taken together, the data suggest that PKC activation decreases the stability of AChR aggregates in the muscle surface membrane. We conclude that PKC plays a crucial role in activity‐dependent synapse reduction and does so, at least in part, by altering AChR stability. J. Neurosci. Res. 61:616–625, 2000. Published 2000 Wiley‐Liss, Inc.
- 6 January 2000
- Published by Wiley in Journal of Neurobiology
- Vol. 42 (1) , 22-32
Involvement of calpains in the destabilization of the acetylcholine receptor clusters in rat myotubes
- 6 January 2000
- Published by Wiley in Journal of Neurobiology
- Vol. 42 (1) , 22-32
Involvement of calpains in the destabilization of the acetylcholine receptor clusters in rat myotubes
- Open Access
- 11 November 1997
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (23) , 12644-12648
Cerebral cortical astroglia from the trisomy 16 mouse, a model for Down syndrome, produce neuronal cholinergic deficits in cell culture
Trisomy 21 (Down syndrome) is associated with a high incidence of Alzheimer disease and with deficits in cholinergic function in humans. We used the trisomy 16 (Ts16) mouse model for Down syndrome to identify the cellular basis for the cholinergic dysfunction. Cholinergic neurons and cerebral cortical astroglia, obtained separately from Ts16 mouse fetuses and their euploid littermates, were cultured in various combinations. Choline acetyltransferase activity and cholinergic neuron number were both depressed in cultures in which both neurons and glia were derived from Ts16 fetuses. Cholinergic function of normal neurons was significantly down-regulated by coculture with Ts16 glia. Conversely, neurons from Ts16 animals could express normal cholinergic function when grown with normal glia. These observations indicate that astroglia may contribute strongly to the abnormal cholinergic function in the mouse Ts16 model for Down syndrome. The Ts16 glia could lack a cholinergic supporting factor present in normal glia or contain a factor that down-regulates cholinergic function.
- 11 November 1997
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (23) , 12644-12648
Open AccessCerebral cortical astroglia from the trisomy 16 mouse, a model for Down syndrome, produce neuronal cholinergic deficits in cell culture
Trisomy 21 (Down syndrome) is associated with a high incidence of Alzheimer disease and with deficits in cholinergic function in humans. We used the trisomy 16 (Ts16) mouse model for Down syndrome to identify the cellular basis for the cholinergic dysfunction. Cholinergic neurons and cerebral cortical astroglia, obtained separately from Ts16 mouse fetuses and their euploid littermates, were cultured in various combinations. Choline acetyltransferase activity and cholinergic neuron number were both depressed in cultures in which both neurons and glia were derived from Ts16 fetuses. Cholinergic function of normal neurons was significantly down-regulated by coculture with Ts16 glia. Conversely, neurons from Ts16 animals could express normal cholinergic function when grown with normal glia. These observations indicate that astroglia may contribute strongly to the abnormal cholinergic function in the mouse Ts16 model for Down syndrome. The Ts16 glia could lack a cholinergic supporting factor present in normal glia or contain a factor that down-regulates cholinergic function.
- 31 December 1986
- Published by Elsevier in Brain and Development
- Vol. 8 (2) , 102
The effects of antiepileptic drugs on developing neurons in culture
- 31 December 1986
- Published by Elsevier in Brain and Development
- Vol. 8 (2) , 102
The effects of antiepileptic drugs on developing neurons in culture
- 1 January 1983
- Published by Wiley in Annals of Neurology
- Vol. 13 (1) , 48-52
Toxic effect of phenytoin on developing cortical neurons in culture
- 1 January 1983
- Published by Wiley in Annals of Neurology
- Vol. 13 (1) , 48-52
Toxic effect of phenytoin on developing cortical neurons in culture